The recent developments in the legal landscape involving Bollywood actors and gutka advertisements have taken an interesting turn as the central government responded to a contempt petition. Notices have been issued to renowned actors such as Akshay Kumar, Shah Rukh Khan, and Ajay Devgn, drawing attention to their association with gutka promotions. This move follows growing concerns about the ethical implications and health risks associated with endorsing gutka products.

In a subsequent hearing on Friday, the government’s counsel provided the court with insights into the Supreme Court’s considerations regarding the contempt petition. There are indications that the case might face dismissal, with the next scheduled hearing set for May 9, 2024. This development sheds light on the complexities of legal proceedings involving celebrity endorsements, especially when connected to products that have potential health hazards.

Shah Rukh Khan, Ajay Devgn, and Akshay Kumar face legal trouble:

Furthermore, the court shared information about Bollywood stalwart Amitabh Bachchan, who reportedly sent a legal notice to a gutka company for featuring him in advertisements even after the termination of his contractual agreement with them. This adds another layer to the ongoing legal saga, illustrating the intricate dynamics between celebrities, contractual obligations, and the promotion of potentially harmful products.

Despite persistent appeals from the petitioner, there has been a notable absence of concrete action from the central government, prompting the High Court to issue yet another notice to the Cabinet Secretary. This ongoing saga highlights the challenges in addressing the concerns raised by the petitioner against both celebrities and gutka companies.

The broader implications of this case delve into the responsibility of celebrities in endorsing products that could have adverse effects on public health. It raises questions about the role of regulatory bodies and the legal framework in place to govern such endorsements. As the legal proceedings continue, it remains to be seen how this case will shape the landscape of celebrity endorsements and their accountability in endorsing products associated with potential health risks.